Quick reference to immune-mediated adverse reactions associated with OPDIVO®
Please see links to U.S. Full Prescribing Information for OPDIVO at http://packageinserts.bms.com/pi/pi_opdivo.pdf and YERVOY® (ipilimumab) at http://packageinserts.bms.com/pi/pi_yervoy.pdf including BOXED WARNING regarding immune-mediated adverse reactions, for YEROY.
HCP Adverse Reactions Guide
Your quick reference to the immune-mediated adverse reactions associated with OPDIVO® treatment. The Immune-Mediated Adverse Reactions (IMARs) Guide App for OPDIVO treatment can be viewed on your phone or tablet providing on-the-go information at your fingertips.
- Learn more about clarifying and addressing OPDIVO associated IMARs
- Find detailed monitoring guidance and symptomatology in quick reference format
- Includes organ-specific IMAR algorithms
Please visit www.OPDIVO.com or call 1-855-OPDIVO-1 (1-855-673-4861) for more information.
From Bristol-Myers Squibb
For U.S. Healthcare Professionals
Read more
